The EPO published patent EP3854804A1 for Shanghai Puyou Biomedical Co., Ltd. covering compositions and methods for preventing and treating atherosclerosis and related diseases including neurological conditions. The patent application includes claims for A61K 38/17 (proteins/peptides), C07K 14/47 (proteins), and C12N 15/867 (viral vectors), with designated states covering all 44 EPC contracting states including major EU economies.

This patent publication is informational and does not impose immediate compliance obligations on third parties. Pharmaceutical and biotechnology companies developing cardiovascular or atherosclerosis treatments should review the patent claims to assess potential freedom-to-operate implications. Patent publication in the EPO Bulletin serves as public notice of the application's pendency and eventual scope if granted.